Novartis Ag (NVS) Divestments (2011 - 2026)
Novartis Ag (NVS) posted Divestments of $62.0 million for Q2 2026, up 3200.0% sequentially from -$2.0 million in Q1 2026, and up 663.64% YoY from $8.1 million in Q2 2025.
Novartis Ag (NVS) Divestments (2011 - 2026) Analysis & Trends
Novartis Ag has reported Divestments for 16 years, with the latest figure at $62.0 million in Q2 2026.
- Quarterly Divestments rose 663.64% year-over-year to $62.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$13.0 million (up 99.64% YoY) and the FY2025 annual result came in at -$88.0 million, down 182.24% from the prior year.
- Divestments rose to $62.0 million in Q2 2026 per NVS's latest filing, from -$2.0 million in the prior quarter.
- Over five years, Divestments peaked at $62.0 million in Q2 2026 and troughed at -$3.6 billion in Q4 2024.
- A 5-year average of -$467.7 million and a median of -$17.0 million in 2023 frame the typical range for Divestments.
- The sharpest annual moves came in 2024 and 2026: Divestments tumbled 44875.0% in 2024, then surged 663.64% in 2026.
- Over 5 years, Divestments stood at -$7.0 million in 2022, then decreased by 14.29% to -$8.0 million in 2023, then sank by 44875.0% to -$3.6 billion in 2024, then jumped by 99.75% to -$9.0 million in 2025, then jumped by 788.89% to $62.0 million in 2026.
- According to Business Quant data, Divestments over the past three periods registered $62.0 million, -$2.0 million, and -$9.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | - |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 62.00 Mn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | - |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | - |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 1.88 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | - |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.00 Mn |
| Mar 31, 2026 | -2.00 Mn |
| Dec 31, 2025 | -9.00 Mn |
| Sep 30, 2025 | -64.00 Mn |
| Jun 30, 2025 | -11.00 Mn |
| Mar 31, 2025 | -4.00 Mn |
| Dec 31, 2024 | -3.60 Bn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | -3.32 Bn |
| Mar 31, 2024 | -279.00 Mn |
| Dec 31, 2023 | -8.00 Mn |
| Sep 30, 2023 | -208.00 Mn |
| Jun 30, 2023 | -84.00 Mn |
| Mar 31, 2023 | -23.00 Mn |
| Dec 31, 2022 | -7.00 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Jun 30, 2022 | -59.00 Mn |
| Mar 31, 2022 | -821.00 Mn |
| Dec 31, 2021 | -343.00 Mn |
| Sep 30, 2021 | -15.00 Mn |